Lock in our best rate for 2 years! I do not recommend stopping aspirin without discussing with your doctor. I do not recommend stopping aspirin without discussing with your doctor.
Asundexian's Phase 3 study results raise hopes for a new class of cardiovascular drugs that has seen clinical setbacks.
The pharma company said asundexian, when combined with antiplatelet therapy, lowered the risk of stroke in patients during ...
Lock in our best rate for 2 years! I do not recommend stopping aspirin without discussing with your doctor. I do not recommend stopping aspirin without discussing with your doctor.
German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a ...
The study suggests that daily aspirin use in older adults may increase their risk of developing anemia, a condition that can ...
For patients who have undergone successful catheter ablation for atrial fibrillation, treatment with rivaroxaban does not offer superior stroke protection versus aspirin.
Prasugrel may be the P2Y12 inhibitor of choice for use in combination with aspirin after PCI in patients with diabetes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback